ライブラリ登録: Guest
Critical Reviews™ in Immunology

年間 6 号発行

ISSN 印刷: 1040-8401

ISSN オンライン: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Mode of Action of Botulinum Neurotoxins: Current Vaccination Strategies and Molecular Immune Recognition

巻 30, 発行 2, 2010, pp. 167-187
DOI: 10.1615/CritRevImmunol.v30.i2.50
Get accessGet access

要約

The action of a botulinum neurotoxin (BoNT) commences by binding at the nerve terminal via its H- (heavy) chain to a cell-surface receptor, which consists of a ganglioside and a cell-surface protein. Binding enables the L-chain, a Zn2+-dependent endopeptidase, to be internalized and act intracellularly, cleaving one or more SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins required for vesicle docking and fusion, which results in reduced neurotransmitter release. Sprouts emerge at motor-nerve terminals that reestablish synaptic contact and lead to restoration of exocytosis. As the terminals recover, sprouts retreat and synaptic function is fully re-established. Neutralizing antibodies (Abs) induced by vaccination can prevent the neuronal changes produced by BoNT. Until recently, vaccines against BoNT have been based on toxins inactivated by treatment with formaldehyde (toxoids) and contain either one (monovalent) or five (pentavalent) toxoids, but formalin-based toxoids have many undesirable side effects. Availability of the gene sequences of BoNT serotypes enabled design of recombinant subunit vaccines that have included the C-terminal domain of the H chain (HC, its subdomains (HC-N and HC-C), the L- (catalytic) chain, and the L-chain expressed with the translocation domain (LCHN). Of these, the HC displays the highest protective ability. Recent vaccines have used whole toxins inactivated by three key mutations at the enzyme active site, which have been found to be very effective in mice against the correlated toxin. Immune responses to BoNTs A and B epitopes are under the host’s MHC (major histocompatibility complex) control. Anti-BoNT/A blocking Abs bind at sites that coincide or overlap with those that bind synaptosomes and to BoNT/B at sites that overlap with synaptotagmin-II and ganglioside-binding sites. Therefore, locations occupied by blocking Abs preclude the respective toxin from binding to its receptor and thus from binding to cell surface. Information on BoNT epitopes for blocking Abs, sites for binding to cell surface receptors, and T-cell epitopes that provide help to B cells making blocking Abs afford a prospect for rational design of stable synthetic vaccines. These constructs should be clinically useful for epitope-selective modulation of Ab responses to restore effective BoNT treatment in immunoresistant patients.

によって引用された
  1. Eichhorn Tolga, Dolimbek Behzod Z., Deeg Katharina, Efferth Thomas, Atassi M. Zouhair, Inhibition in vivo of the activity of botulinum neurotoxin A by small molecules selected by virtual screening, Toxicon, 60, 6, 2012. Crossref

  2. Karalewitz Andrew P-A, Barbieri Joseph T, Vaccines against botulism, Current Opinion in Microbiology, 15, 3, 2012. Crossref

  3. George Katherine S., Kiani Hamid, Witherow Helen, Effectiveness of botulinum toxin B in the treatment of drooling, British Journal of Oral and Maxillofacial Surgery, 51, 8, 2013. Crossref

  4. Henkel James S., Tepp William H., Przedpelski Amanda, Fritz Robert B., Johnson Eric A., Barbieri Joseph T., Subunit vaccine efficacy against Botulinum neurotoxin subtypes, Vaccine, 29, 44, 2011. Crossref

  5. Atassi M. Zouhair, Taruishi Midori, Naqvi Masooma, Steward Lance E., Aoki K. Roger, Synaptotagmin II and Gangliosides Bind Independently with Botulinum Neurotoxin B but Each Restrains the Other, The Protein Journal, 33, 3, 2014. Crossref

  6. Atassi M. Zouhair, Oshima Minako, Dolimbek Behzod Z., Aoki K. Roger, Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains, Immunobiology, 217, 1, 2012. Crossref

  7. Yu YunZhou, Shi DanYang, Liu Si, Gong Zheng-Wei, Wang Shuang, Sun ZhiWei, Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system, Human Vaccines & Immunotherapeutics, 11, 2, 2015. Crossref

  8. Lim Erle C. H., Seet Raymond C. S., Use of botulinum toxin in the neurology clinic, Nature Reviews Neurology, 6, 11, 2010. Crossref

  9. Moreira G.M.S.G., Cunha C.E.P., Salvarani F.M., Gonçalves L.A., Pires P.S., Conceição F.R., Lobato F.C.F., Production of recombinant botulism antigens: A review of expression systems, Anaerobe, 28, 2014. Crossref

  10. Atassi M. Zouhair, Dolimbek Behzod Z., Steward Lance E., Aoki K. Roger, Inhibition of Botulinum Neurotoxin A Toxic Action In Vivo by Synthetic Synaptosome- and Blocking Antibody-Binding Regions, The Protein Journal, 29, 5, 2010. Crossref

  11. Lu Alex Y., Yeung Jacky T., Gerrard Jason L., Michaelides Elias M., Sekula Raymond F., Bulsara Ketan R., Hemifacial Spasm and Neurovascular Compression, The Scientific World Journal, 2014, 2014. Crossref

  12. Atassi M. Zouhair, Dolimbek Behzod Z., Steward Lance E., Aoki K. Roger, Antibodies against a synthetic peptide designed to mimic a surface area of the H chain of botulinum neurotoxin A, Immunology Letters, 142, 1-2, 2012. Crossref

  13. Tang Christopher G., Novakovic Daniel, Mor Niv, Blitzer Andrew, Onabotulinum toxin A dosage trends over time for adductor spasmodic dysphonia: A 15-year experience, The Laryngoscope, 126, 3, 2016. Crossref

  14. Dolimbek Behzod Z., Aoki K. Roger, Atassi M. Zouhair, Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol–peptide conjugates, Immunology Letters, 137, 1-2, 2011. Crossref

  15. Lim Erle C.H., Quek Amy M.L., Seet Raymond C.S., Accurate targeting of botulinum toxin injections: How to and why, Parkinsonism & Related Disorders, 17, 2011. Crossref

  16. Liu Bo, Shi DanYang, Chang ShaoHong, Gong Xin, Yu YunZhou, Sun ZhiWei, Wu Jun, Characterization and immunological activity of different forms of recombinant secreted Hc of botulinum neurotoxin serotype B products expressed in yeast, Scientific Reports, 5, 1, 2015. Crossref

  17. Vijayalakshmi Ayyar B., Tajhya Rajeev B., Beeton Christine, Zouhair Atassi M., Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin, Scientific Reports, 5, 1, 2015. Crossref

  18. Smith Garry R., Caglič Dejan, Čapek Petr, Zhang Yan, Godbole Sujata, Reitz Allen B., Dickerson Tobin J., Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: Extending towards the β-exosite, Bioorganic & Medicinal Chemistry Letters, 22, 11, 2012. Crossref

  19. Atassi M.Z., Molecular basis of immunogenicity to botulinum neurotoxins and uses of the defined antigenic regions, Toxicon, 107, 2015. Crossref

  20. Kroken Abby R., Karalewitz Andrew P.-A., Fu Zhuji, Baldwin Michael R., Kim Jung-Ja P., Barbieri Joseph T., Unique ganglioside binding by botulinum neurotoxins C and D-SA, FEBS Journal, 278, 23, 2011. Crossref

  21. Ruwona Tinashe B., Xu Haiyue, Li Junwei, Diaz-Arévalo Diana, Kumar Amit, Zeng Mingtao, Cui Zhengrong, Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles, Human Vaccines & Immunotherapeutics, 12, 5, 2016. Crossref

  22. Ayyar B. Vijayalakshmi, Atassi M. Zouhair, Effects of membrane properties on the binding activities of the H N and H C heavy-chain domains of botulinum neurotoxin A, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1864, 12, 2016. Crossref

  23. Moreira Clóvis, da Cunha Carlos Eduardo Pouey, Moreira Gustavo Marçal Schmidt Garcia, Mendonça Marcelo, Salvarani Felipe Masiero, Moreira Ângela Nunes, Conceição Fabricio Rochedo, Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D, Anaerobe, 40, 2016. Crossref

  24. Oliveira Júnior Carlos Augusto de, Silva Rodrigo Otávio Silveira, Olinda Roberio Gomes, Lobato Francisco Carlos Faria, Botulism in non-ruminants in Brazil, Ciência Rural, 46, 12, 2016. Crossref

  25. Silva Rodrigo Otávio Silveira, Oliveira Junior Carlos Augusto, Gonçalves Luciana Aramuni, Lobato Francisco Carlos Faria, Botulism in ruminants in Brazil, Ciência Rural, 46, 8, 2016. Crossref

  26. Zheng Feixia, Ye Xiuyun, Shi Xulai, Poonit Neha Devi, Lin Zhongdong, Management of Refractory Orofacial Dyskinesia Caused by Anti-N-methyl-d-aspartate Receptor Encephalitis Using Botulinum Toxin, Frontiers in Neurology, 9, 2018. Crossref

  27. Marchese M.R., D'Alatri L., Bentivoglio A.R., Paludetti G., OnabotulinumtoxinA for adductor spasmodic dysphonia (ADSD): Functional results and the role of dosage, Toxicon, 155, 2018. Crossref

  28. Adler Michael, Gul Nizamettin, Eitzen Edward, Oyler George, Molles Brian, Prevention and Treatment of Botulism, in Molecular Aspects of Botulinum Neurotoxin, 2014. Crossref

  29. Dolimbek Behzod Z., Steward Lance E., Aoki K. Roger, Atassi M. Zouhair, Location of the Synaptosome-Binding Regions on Botulinum Neurotoxin B, Biochemistry, 51, 1, 2012. Crossref

  30. O'Flaherty Sarah, Klaenhammer Todd R., Dudley E. G., Multivalent Chromosomal Expression of the Clostridium botulinum Serotype A Neurotoxin Heavy-Chain Antigen and the Bacillus anthracis Protective Antigen in Lactobacillus acidophilus, Applied and Environmental Microbiology, 82, 20, 2016. Crossref

  31. Li Zhen, Lu Jiansheng, Tan Xiao, Wang Rong, Xu Qing, Yu Yunzhou, Yang Zhixin, Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E, Toxins, 14, 2, 2022. Crossref

近刊の記事

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain